

+357 96 182730



hello@CBG.com.cy



Events

A community calendar shared and populated by CBG members.



Directory

We list verified experts, funding options, and exlusive offers.



Giveaways

Free prizes offered up by magazines, radio stations, and more.



Coming Soon

Wouldn’t it be great to have a better way to network?

Discussion – 

0

Discussion – 

0

Elon Musk: Neuralink Patient Controls Mouse with Thoughts

Breakthrough in Neuralink Technology: Controlling a Computer Mouse with the Mind

In a remarkable advancement, a patient who underwent a Neuralink brain implant procedure can now manipulate a computer mouse through thought alone, as disclosed by the company’s founder, Elon Musk.
During a live session on the social media platform X, Musk revealed, “[The] patient seems to have made a full recovery with no ill effects that we are aware of and is able to control the mouse, move the mouse around the screen just by thinking.”

Revolutionizing Human-Machine Interaction

Neuralink, spearheaded by billionaire entrepreneur Elon Musk, specializes in developing brain implants intended to harness neural signals for controlling external devices. With a mission to restore lost functionalities like vision, motor skills, and speech, Neuralink represents a pioneering venture in the realm of neurotechnology.
While Neuralink has not yet provided a formal statement on this latest development, it marks a significant milestone in the company’s journey.

Merging Mind and Machine: The Neuralink Procedure

In January, Neuralink achieved a major breakthrough by successfully implanting its device in a human subject for the first time. Employing sophisticated robotic technology, the company ensures precise placement of the implant within the brain.
Elaborating on the process, Musk, who also serves as the CEO of Tesla, explained Neuralink’s objective of translating cognitive impulses into tangible actions. He expressed the aspiration to maximize the efficacy of this technology, envisioning scenarios where users can execute complex tasks merely by thought, such as maneuvering a computer mouse to interact with digital interfaces.

Advancing Towards Commercialization

Neuralink’s journey towards commercial viability commenced with the recruitment of participants for its inaugural in-human clinical trial. After securing approval from the U.S. Food and Drug Administration in May, the company initiated the trial process, seeking to validate the safety and efficacy of its groundbreaking technology.
Undoubtedly, the successful implementation of Neuralink’s brain implant in human subjects represents a pivotal phase in its evolution. However, the path to widespread adoption entails rigorous data collection and testing to meet the stringent regulatory standards set forth by the FDA.
As Neuralink continues to push the boundaries of neurotechnology, the prospect of seamlessly integrating human cognition with machine interfaces opens up unprecedented possibilities for enhancing human capabilities and quality of life.

0 Comments

Submit a Comment

Your email address will not be published. Required fields are marked *

You May Also Like